SPHERE, NHMRC Centre of Research Excellence, Department of General Practice, School of Public Health and Preventive Medicine, Monash University , Melbourne, Victoria 3004
Auto-generated profile, based on publicly available information
Elizabeth Lehman
SPHERE, NHMRC Centre of Research Excellence, Department of General Practice, School of Public Health and Preventive Medicine, Monash University , Melbourne, Victoria 3004
Summary: Background: During the coronavirus disease 2019 (COVID‐19) pandemic, the Australian state of Victoria (in particular, its capital, Melbourne) experienced some of the longest lockdowns in the world.Objective: This repeated cross‐sectional study examined changes between March to June 2019 (pre‐pandemic) and April to August 2022 (6 to 11 months following pandemic‐related lockdowns) in overweight and obesity prevalence, physical activity, sedentary behaviour, sleep, diet quality, and health‐related quality of life (HRQoL) among primary school children in north‐east Victoria, Australia.Methods: Height and weight were measured for Grade 2, 4, and 6 students in 2019 (3889 children) and 2022 (1816 children). Grade 4 and 6 students self‐reported on their movement behaviours, diet quality, and HRQoL.Results: Participation declined among schools (2019:56%, 2022:34%) and students (2019:87%, 2022:75%). Compared to children in 2019, children in 2022 had a higher prevalence of overweight and obesity; were less likely to have met guidelines for moderate‐to‐vigorous physical activity, recreational screen time, and vegetable consumption; had higher intakes of takeaway food, energy‐dense nutrient‐poor snacks, and sugar‐sweetened beverages; and had lower HRQoL.Conclusion: Children's health‐related behaviours and outcomes seemed not to have returned to pre‐pandemic levels 6 to 11 months after the final lockdowns lifted for their communities. Continued monitoring and interventions targeting the drivers of childhood obesity are urgently needed.
1 September 2026 in International Journal of Pharmacy Practice
Objectives: Australia has commenced implementing contraceptive resupply and prescribing by community pharmacists to improve equity in method access. This study aimed to investigate pharmacist’s acceptability of hormonal contraceptive resupply and prescribing. Methods: Participants were recruited via convenience sampling and had provided contraceptive counseling consistent with the ALLIANCE intervention (i.e. structured, patient-centered, effectiveness-based care) to women seeking the emergency contraceptive pill or presenting prescriptions for medical abortion medicines. This qualitative descriptive study was embedded within the ALLIANCE trial, whose process evaluation included semi-structured interviews with pharmacist participants. The interview guide, containing questions on pharmacists’ views of the resupply and prescribing service, was reviewed by the ALLIANCE Trial Chief Investigators and piloted in June 2024 with the SPHERE Pharmacy Advisory Circle. Thirteen questions were developed using the Theoretical Framework of Acceptability (TFA). Two researchers conducted line-by-line coding using an iteratively refined codebook, with codes mapped to TFA constructs to examine operationalization in pharmacists’ delivery of hormonal contraception. Key findings: Although pharmacists (n = 24) perceived that the service could be cost- and time-saving to patients, they raised concerns of unintentionally removing general practitioner (GP)-led monitoring of patients and overstepping GPs’ roles. While pharmacists felt confident in their expertise and generally supported the service, they expressed hesitation about initiating contraceptive prescriptions, for which they felt further training and access to comprehensive medical records were required. Additional barriers included increased workload pressures, lack of reimbursement, and inadequate staffing. Conclusions: Overall, providing a resupply service appears to be acceptable to community pharmacists because it relies on the GP’s initial assessment but prescribing less so. However, evaluation is needed post-implementation to explore sustainability, feasibility, and long-term impact on patient outcomes.